A detailed history of Northern Trust Corp transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 1,314,610 shares of RXRX stock, worth $9.18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,314,610
Previous 1,286,690 2.17%
Holding current value
$9.18 Million
Previous $12.8 Million 23.14%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$7.35 - $10.05 $205,212 - $280,596
27,920 Added 2.17%
1,314,610 $9.86 Million
Q1 2024

May 14, 2024

SELL
$9.13 - $15.52 $81,229 - $138,081
-8,897 Reduced 0.69%
1,286,690 $12.8 Million
Q4 2023

Feb 13, 2024

SELL
$5.09 - $10.79 $67,926 - $143,992
-13,345 Reduced 1.02%
1,295,587 $12.8 Million
Q3 2023

Nov 13, 2023

BUY
$6.59 - $15.86 $375,267 - $903,147
56,945 Added 4.55%
1,308,932 $10 Million
Q2 2023

Aug 11, 2023

BUY
$4.56 - $9.94 $438,717 - $956,327
96,210 Added 8.32%
1,251,987 $9.35 Million
Q1 2023

May 15, 2023

SELL
$6.42 - $9.64 $25,204 - $37,846
-3,926 Reduced 0.34%
1,155,777 $7.71 Million
Q4 2022

Feb 13, 2023

BUY
$7.16 - $12.7 $186,195 - $330,263
26,005 Added 2.29%
1,159,703 $8.94 Million
Q3 2022

Nov 14, 2022

BUY
$7.83 - $13.6 $1.19 Million - $2.07 Million
152,416 Added 15.53%
1,133,698 $12.1 Million
Q2 2022

Aug 12, 2022

BUY
$5.04 - $9.26 $613,559 - $1.13 Million
121,738 Added 14.16%
981,282 $7.99 Million
Q1 2022

May 13, 2022

SELL
$6.16 - $18.03 $162,728 - $476,298
-26,417 Reduced 2.98%
859,544 $6.15 Million
Q4 2021

Feb 08, 2022

BUY
$16.14 - $21.86 $10.3 Million - $13.9 Million
635,290 Added 253.44%
885,961 $15.2 Million
Q3 2021

Nov 15, 2021

BUY
$19.03 - $41.33 $157,853 - $342,832
8,295 Added 3.42%
250,671 $5.77 Million
Q2 2021

Aug 13, 2021

BUY
$18.0 - $37.42 $4.36 Million - $9.07 Million
242,376 New
242,376 $8.85 Million

Others Institutions Holding RXRX

About RECURSION PHARMACEUTICALS, INC.


  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.26B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.